Current Ratio of Arcus Biosciences, Inc. from 30 Sep 2018 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
Arcus Biosciences, Inc. quarterly Current Ratio in x history and change rate from 30 Sep 2018 to 31 Dec 2025.
- Arcus Biosciences, Inc. Current Ratio for the quarter ending 31 Dec 2025 was 4.43x, a 12% decline year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
Arcus Biosciences, Inc. Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 4.43x | -0.59x | -12% | 31 Dec 2025 |
| Q3 2025 | 4.46x | -0.58x | -12% | 30 Sep 2025 |
| Q2 2025 | 4.89x | +0.06x | +1.2% | 30 Jun 2025 |
| Q1 2025 | 5.04x | +0.14x | +2.9% | 31 Mar 2025 |
| Q4 2024 | 5.01x | +0.01x | +0.24% | 31 Dec 2024 |
| Q3 2024 | 5.04x | -0.21x | -4% | 30 Sep 2024 |
| Q2 2024 | 4.83x | -0.89x | -16% | 30 Jun 2024 |
| Q1 2024 | 4.9x | -1.28x | -21% | 31 Mar 2024 |
| Q4 2023 | 5x | -1.7x | -25% | 31 Dec 2023 |
| Q3 2023 | 5.25x | -2.01x | -28% | 30 Sep 2023 |
| Q2 2023 | 5.72x | -1.06x | -16% | 30 Jun 2023 |
| Q1 2023 | 6.18x | -0.17x | -2.7% | 31 Mar 2023 |
| Q4 2022 | 6.7x | +0.76x | +13% | 31 Dec 2022 |
| Q3 2022 | 7.26x | +1.82x | +33% | 30 Sep 2022 |
| Q2 2022 | 6.78x | +1.07x | +19% | 30 Jun 2022 |
| Q1 2022 | 6.36x | +0.12x | +2% | 31 Mar 2022 |
| Q4 2021 | 5.94x | -0.34x | -5.4% | 31 Dec 2021 |
| Q3 2021 | 5.44x | -1.16x | -18% | 30 Sep 2021 |
| Q2 2021 | 5.71x | -4.13x | -42% | 30 Jun 2021 |
| Q1 2021 | 6.23x | -2.39x | -28% | 31 Mar 2021 |
| Q4 2020 | 6.28x | -3.42x | -35% | 31 Dec 2020 |
| Q3 2020 | 6.6x | -4.56x | -41% | 30 Sep 2020 |
| Q2 2020 | 9.84x | -2.77x | -22% | 30 Jun 2020 |
| Q1 2020 | 8.62x | -6.42x | -43% | 31 Mar 2020 |
| Q4 2019 | 9.7x | -7.03x | -42% | 31 Dec 2019 |
| Q3 2019 | 11.16x | -5.37x | -32% | 30 Sep 2019 |
| Q2 2019 | 12.61x | 30 Jun 2019 | ||
| Q1 2019 | 15.04x | 31 Mar 2019 | ||
| Q4 2018 | 16.73x | 31 Dec 2018 | ||
| Q3 2018 | 16.53x | 30 Sep 2018 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.